Navigation Links
Watson Enters into Agreement to Acquire Products Related to Perrigo's Acquisition of Paddock Laboratories
Date:7/26/2011

PARSIPPANY, N.J., July 26, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the merger between Perrigo Company and Paddock Laboratories.  The portfolio consists of six products, including four FDA-approved products and two undisclosed development-stage products.  Commercialized products in the portfolio include:

Ciclopirox shampoo 1%
Ammonium Lactate Cream 12%
Ammonium Lactate Lotion 12%
Promethazine HCl Suppositories 12.5 and 25 mg

Perrigo will supply the products to Watson under a Manufacturing and Supply Agreement until manufacturing is transferred to Watson or a third party. Additional details, including financial terms, have not been disclosed.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspective of existing information as of the date of this release. It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors, risks and uncertainties affecting Wats
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Second Quarter 2011 Net Revenue Exceeds $1 Billion; Non-GAAP EPS of $1.01
2. Watson Confirms JALYN™ Patent Challenge
3. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
4. Watson Confirms Vyvanse® Patent Challenge
5. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings
6. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
7. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
8. Watson Confirms AVODART(R) Patent Challenge
9. Watson Confirms Court Decision Rejecting Tevas Motion to Prevent Launch of Generic SEASONIQUE®
10. Watsons Nabumetone Tablets Receive FDA Approval
11. Watson Confirms Pataday™ Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... Company"), a specialty pharmaceutical company focused on pharmaceuticals for ... the 27th Annual ROTH Conference, which will take place ... Dana Point, California . Management,s presentation ... a.m. Pacific Time (12:00 p.m. Eastern Time) in the ...
(Date:3/3/2015)... 2015  Web Industries, Inc., a leading provider ... Medical Device, Advanced Composites, Consumer Products, and Wire ... Medical Specialties Preferred Converter by 3M,s Medical Specialties ... to streamline their supply chains by using Web ... materials, intermediate converting services, and contract manufacturing and ...
(Date:3/3/2015)... 2015 Research and Markets ( ... "Global Ultrasound Equipment Market 2015-2019" report ... The Global Ultrasound Equipment market to grow at ... Ultrasound equipment are used to examine ... extensively used by cardiologists, radiologists, surgeons, obstetricians, and ...
Breaking Medicine Technology:Web Industries Receives 3M Preferred Converter Status 2Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2
... ANN ARBOR, Mich., May 12 Velcura Therapeutics, ... trial for,its lead compound, VEL-0230, which the company ... and other bone diseases. In,extensive preclinical studies, VEL-0230 ... stimulates bone formation and inhibits,bone loss. Taken together, ...
... Systems, Inc.,(OTC Bulletin Board: ABOS) announced today that ... and Drug Administration ("FDA") of an,Investigational Device Exemption ... Arbios, extracorporeal (outside the body) liver assist,device for ... liver disease., "We are pleased to have ...
Cached Medicine Technology:Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5
(Date:3/4/2015)... 04, 2015 Rocket Builders’ “Ready to ... companies that have the best prospect for growth according ... we choose the Ready to Rocket companies, we are ... innovation with market opportunity. Prizm Media Inc. is an ... customers at the right time,” said Reg Nordman, Managing ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The medical ... companies whose management forgot – or ignored or didn't ... Validate the market based on physician input before proceeding ... – more specifically, founders – become so enamored of ... key question: Will physicians use the device?” says ...
(Date:3/3/2015)... Centerville, MA (PRWEB) March 04, 2015 ... and educational facilities design and construction event for ... Hotel Boston Massachusetts announced key building envelope related ... credits. , Workshops include: , Curtain ... installed in many health care and laboratory facilities ...
(Date:3/3/2015)... 03, 2015 Anik Singal's ... program for ambitious online marketers has become the ... community. Widespread media attention surrounding the course's general ... reporter Tiffany Hendricks, prompting her to review the ... , "One of the biggest keys to success ...
(Date:3/3/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ... Attendance / Workforce Management solutions, announced that Innovative ... Workforce Management / Time and Attendance system ... , Since 2004, Innovative Services’ mission has been ... best quality of life. The company is committed ...
Breaking Medicine News(10 mins):Health News:Healthcare Lead Generation Leader Prizm Media Inc. is “Ready to Rocket” 2Health News:Healthcare Lead Generation Leader Prizm Media Inc. is “Ready to Rocket” 3Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 2Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 3Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 4Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 5Health News:Building Envelope Code and Regulation Sessions at MED-Ed Facilities 6Health News:Anik Singal's Profit Academy - Review Of New IM Training Program Released 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 2Health News:Innovative Services, Inc. Successfully Migrates to Cloud-Based NOVAtime Workforce Management Solution to Support Growth and Improve Payroll Processing Time 3
... Dynamics Company,Ltd.) (TSX: IDL), the global leader in ... that it has been awarded a contract by,the ... India for,five X-Series 1600 DR systems with X4C ... placed for DR equipment by the government in,India ...
... not be the major cause of hyperactivity in children. Genetics, ... just as important. , A review ... actually affected by what they eat. A combination of food, ... with no single factor to blame. , Foods which ...
... Transplant,Foundation (MTF) will provide military hospitals with special ... for injured servicemen and,women., Military hospitals and ... for cartilage transplantation and meniscus grafts used for,joint ... tissue are in high,demand for U.S. servicemen and ...
... has awarded one of 14 Clinical and Translational Science ... Boston University Medical (BUMC) and Charles River Campuses and ... CTSAs awarded in 2007, and 12 awarded in 2006, ... a national consortium of select centers that will transform ...
... H. Antman, MD, provost of Boston University Medical Campus ... be honored with the Distinguished Service Award for Scientific ... at their annual meeting in Chicago this weekend. Antman, ... cancer, is widely recognized for her development of a ...
... a Useful Tool in Detection, as Sensitive as MRI ... Invasive Cancers and Perhaps More So for DCIS, NEWPORT ... June issue of Radiology, researchers at The George Washington,University Medical ... is highly sensitive in detecting the,presence of cancer. The researchers ...
Cached Medicine News:Health News:IDC awarded India's largest state government contract for digital radiography systems 2Health News:IDC awarded India's largest state government contract for digital radiography systems 3Health News:Children's diet not the main cause of ADHD 2Health News:BUMC, BMC receives Clinical and Translational Science Award from NIH 2Health News:BUMC provost, BUSM dean, to be honored at world's largest meeting of oncology professionals 2Health News:Breast-Specific Gamma Imaging (BSGI) Found to Be Highly Sensitive for Early Stage Breast Cancer 2
... Vitrectomy Lenses are a family of single-use direct ... of a particular region of the retinal surface ... less than 1 gram and is formed and ... of a human cornea. Lenses come in boxes ...
... The AFX Lens is a ... use in an air-filled eye. ... as a primary air-fluid exchange ... and sutureless design make it ...
... The Chalam 30° Prism ... pathologies and are recommended for ... etc.) and Rhegmatogenus retinal detachment. ... panretinal photocoagulation and other midperipheral ...
... The 45° Prism ... fundus pathologies and are ... detachments (PDR, BRVO etc.) ... They can be used ...
Medicine Products: